Frontiers in Psychology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2024-09-11 133d07a4m90暂无昵称来自黑龙江省

请问投稿入口在哪儿

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2023-07-27 ms8000000815286227 来自天津

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：神经
经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-05-25 ms9000000646477775

我的文章返修后在编辑评估那一个月了，有这种情况吗

149 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2023-03-21 王小狼来自四川省

杂志被ON HOLD了各位小心

126 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-12-24 ms8000000475551313 来自宾夕法尼亚

审稿速度:3.0
偏重的研究方向：肿瘤患者心理
经验分享：挺快的。谁知道这本杂志是几区的

129 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-09-06 ms1000001665225962

审稿速度:3.0
经验分享：已接收，在等在线发表

145 0

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-08-31 ms6000001490774932

审稿速度:1.0 | 投稿命中率:95.0
经验分享：挺快的

126 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-08-31 ms6000001490774932

审稿速度:1.0 | 投稿命中率:95.0
经验分享：挺快的

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2022-07-27 ms2000001453750499

准备投稿

128 0

[GetPortalCommentsPageByObjectIdResponse(id=2225262, encodeId=977a2225262c4, content=请问投稿入口在哪儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e073641463, createdName=133d07a4m90暂无昵称, createdTime=Wed Sep 11 21:36:21 CST 2024, time=2024-09-11, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2150134, encodeId=cf882150134b5, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经 经验分享：目前审稿人都同意发表了，但是卡在RF阶段，编辑两周多了还没给回复，想问问有没有大神之前遇到过这种情况？能给解释一下是什么原因吗？等的好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5915686915, createdName=ms8000000815286227, createdTime=Thu Jul 27 17:02:43 CST 2023, time=2023-07-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1222217, encodeId=a02f122221eb5, content=我的文章返修后在编辑评估那一个月了，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb425616754, createdName=ms9000000646477775, createdTime=Wed May 25 06:31:05 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120843, encodeId=7c13212084300, content=杂志被ON HOLD了各位小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/2e13486bf93e4a9a8c46e45eb248d66f/1efec809946e4adea6224ee6aa95af14.jpg, createdBy=93c45445432, createdName=王小狼, createdTime=Tue Mar 21 18:53:51 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2107371, encodeId=ab67210e37122, content=审稿速度:3.0 偏重的研究方向：肿瘤患者心理 经验分享：挺快的。谁知道这本杂志是几区的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeb55650702, createdName=ms8000000475551313, createdTime=Sat Dec 24 23:23:26 CST 2022, time=2022-12-24, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1247542, encodeId=57ad124e54232, content=审稿速度:3.0 经验分享：已接收，在等在线发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffca5538093, createdName=ms1000001665225962, createdTime=Tue Sep 06 20:27:35 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242263, encodeId=646c1242263a9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:53:47 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242262, encodeId=cc0e1242262c5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5da8301101, createdName=ms6000001490774932, createdTime=Wed Aug 31 13:52:51 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235065, encodeId=8d921235065b6, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14025510914, createdName=ms2000001453750499, createdTime=Wed Jul 27 14:59:19 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955132, encodeId=1831955132e1, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床心理学 经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ffd98531, createdName=Monica2014, createdTime=Thu Apr 08 09:37:27 CST 2021, time=2021-04-08, status=1, ipAttribution=)]

2021-04-08 Monica2014

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床心理学
经验分享：文章主题是COVID-19相关的，期刊没有收版面费，从投稿到接受不到4个月。

173 10

展开10条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务